Skip directly to content

BICARBONATE DE SODIUM INJECTABLE USP

Product Information

Prescribing Information (download PDF, 403KB)

Product Communication

June 30, 2017 Important Safety Information on Type I Recall Sodium Bicarbonate Inj 8.4% 50 mL vials - Risk of Infection Due to Potential Microbial Contamination (download PDF, 798KB)

June 23, 2017 NEWS REGARDING SODIUM BICARBONATE INJECTION 8.4% (download PDF, 798KB)

June 21, 2017 Second Notification (download PDF, 798KB)

June 20, 2017 Client Letter (download PDF, 798KB)

Canadian regulations limit the scope of information we are permitted to give on prescription drugs via the Internet or other means. Please consult a qualified health professional for more detailed information.

Please contact Pfizer Canada Medical Information at 1 800 463-6001 with any comments or inquiries.

If you encounter technical difficulties in viewing our product information please contact Pfizer.ca